Intellipharmaceutics International Inc. (IPCI)

[wimuskyfisherman]

Sprot- As I said they had an $8 target on IPCI... If they had been doing their job, they would have known there was a good chance of a lawsuit. They should have downgraded before the lawsuit. It seems like most(not just this one) analysts downgrade way too late. How about the analyst writing a note at Rexista filing saying this may cause Purdue to sue and it may take many years to commercialize and issue a downgrade at that time.

While we are discussing IPCI analysts I have another complaint. Some of them have way too high estimates for Seroquel revenue. I have been saying this for a few weeks that Seroquel quarterly revenues will be about $3M- maybe a little more. Some of these analysts have also built in revenue from Pristiq and Lamictal for 2018 numbers. I just want to caution everyone that these drugs are not approved yet... And some of these numbers being thrown around by the analysts are... To put it nicely, a little to optimistic. I am going to leave it at that for now but IPCI has not forecasted the high numbers given by these analysts and everyone should review these numbers with caution.